Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 22, 2012

View Archived Issues

Researchers at Acceleron Pharma patent new fusion proteins for cancer

First-in-man continuous levodopa/carbidopa study begins enrollment

Research collaboration for rare pediatric diseases established

PlGF as a novel biomarker for risk assessment in patients with light-chain amyloidosis

Nymox to commence study evaluating repeat injections of NX-1207

Recently reported data support phase II study of ALS-2200

Phase III perindopril/amlodipine fixed-dose combination study meets primary endpoint

Taiho presents data on TAS-2985, a novel inhibitor of FGFR

Antisense oligonucleotide drug targets alpha-1-antitrypsin deficiency

Bridged nucleic acid technology improves hypertriglyceridemia in mice

Klotho promoter hypermethylation linked to survival in glioblastoma multiforme

French group presents new agents for CML

Numedicus synthesizes novel AMPA receptor agonists

Scientists at Daiichi Sankyo prepare new 11-beta-HSD1 inhibitors

Adamed divulges novel fusion proteins for cancer

Researchers at Pfizer present new acetyl-CoA carboxylase inhibitors

New monoclonal antibodies for cancer presented by U.S. researchers

Paladin Labs launches sublingual grass pollen immunotherapy tablet in Canada

Novel agents for tuberculosis patented by GlaxoSmithKline

Botox approved for severe primary axillary hyperhidrosis in Japan

Everolimus approved in new TSC indications in Japan

Phase IIa trial begins of MediciNova's ibudilast

Pfizer launches Tygacil in Japan

Recruitment begins in pivotal phase IIb trial of GFT-505

FDA orphan drug designation granted to OXi-4503

EMA to begin formal review of macitentan MAA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...